The past is not always a prediction of the future,
Post# of 72440
Wednesday, February 10, 2016
Cellceutix Meets With FDA for Phase 2 Clinical Trial of Kevetrin for Ovarian CancerMarketwired (Wed, Feb 10)
Tuesday, February 9, 2016
Cellceutix to Submit Special Protocol Assessment Request to FDA for Phase 3 Clinical Study of Antibiotic Brilacidin for ABSSSIMarketwired (Tue, Feb 9)
Monday, February 8, 2016
CELLCEUTIX CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Feb